Established in September 2020 with a registered capital of RMB 10 million and a total investment of RMB 100 million, Jiangsu Hainekon Bio-Tech Co., Ltd. (hereinafter referred to as "Hainekon" or "the Company") is a high-tech enterprise focusing on the R&D, production and sales of high quality EPA/DHA products.The manufacturing site is located in the beautiful scenery of Qiandeng ancient town which is sitting between the west of Shanghai and the east of Suzhou, a place boasting with convenient transportation domestically and internationally. The plant and production facilities will be built in two stages.The plant occupied an area of 6,300 ㎡ and some equipments will be up to running in June, and full construction will be completed by the end of 2021. With the designed manufacturing capacity for EPA/DHA in the facility of 3200 metric tons, the trial production of EPA/DHA products is planned in June 2021, and the full scale running is expected by the end 2021.

Leading by top scientists from the Omega-3 field from oversea, the R&D team in Hainekon consists of more than 20 staffs with at least college training background from various Chinese institutes. Equiped with State-Of-The-Art equipments including short-path distillation, fractional distillation, chromatography, etc, EPA/DHA products produced from this facility are of not only high purity but in a highest standard in terms of safety to human health. The application of our EPA/DHA products is from pharmaceutical intermediates to APIs to functional foods already in the market.

Interested parties, please send a resume tohr@HNK.com.cn（This mailbox is for recruitment use only）